Geron (GERN) Gains from Investment Securities (2010 - 2024)
Geron's (GERN) quarterly Gains from Investment Securities came in at $40.8 million in Q4 2024, down 44.1% year-on-year from $73.0 million in Q1 2024, and up 13500.0% quarter-over-quarter from $300000.0 in Q3 2024.
Geron (GERN) Gains from Investment Securities (2010 - 2024) Analysis & Trends
Geron has disclosed Gains from Investment Securities across 14 years of filings, most recently posting $40.8 million for Q4 2024.
- Gains from Investment Securities for Q4 2024 came in at $40.8 million, down 44.1% year-over-year; the trailing twelve-month figure through Dec 2024 was $41.2 million (down 43.55% YoY), and the FY2024 annual result was $76.0 million, up 4.09% from the prior year.
- Gains from Investment Securities came in at $40.8 million for Q4 2024 at Geron, up from $300000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $73.0 million in Q4 2023 to a low of -$499000.0 in Q2 2020.
- The 5-year median for Gains from Investment Securities is $363500.0 (2020), against an average of $11.8 million.
- Across the five-year window, Gains from Investment Securities sank 570.75% in 2020 and jumped 2561.96% in 2023, its largest moves.
- Geron's Gains from Investment Securities stood at -$131000.0 in 2020, then surged by 1041.22% to $1.2 million in 2021, then jumped by 122.36% to $2.7 million in 2022, then surged by 2561.96% to $73.0 million in 2023, then plunged by 44.1% to $40.8 million in 2024.
- The last three Gains from Investment Securities figures came in at $40.8 million (Q4 2024), $300000.0 (Q3 2024), and $100000.0 (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Geron | 729,618.77 | 729,618.77 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 40.80 Mn |
| Dec 31, 2024 | 40.80 Mn |
| Sep 30, 2024 | 300,000.00 |
| Sep 30, 2024 | 300,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Dec 31, 2023 | 72.98 Mn |
| Dec 31, 2023 | 72.98 Mn |
| Dec 31, 2022 | 2.74 Mn |
| Dec 31, 2022 | 2.74 Mn |
| Mar 31, 2021 | 1.23 Mn |
| Mar 31, 2021 | 1.23 Mn |
| Dec 31, 2020 | -131,000.00 |
| Dec 31, 2020 | -131,000.00 |
| Sep 30, 2020 | 427,000.00 |
| Sep 30, 2020 | 427,000.00 |
| Jun 30, 2020 | -499,000.00 |
| Jun 30, 2020 | -499,000.00 |
| Mar 31, 2020 | 220,000.00 |
| Mar 31, 2020 | 220,000.00 |